XSpectra - a new generation of x-ray inspection systems
Europe Flag

Eu fundend No 849381

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 849381.

One more step for a better health

Increasing attention is paid every year to the quality of pharmaceutical products.
European and North American regulations, in particular, continue to raise quality levels required for drug commercialisation. The rise in the production demands further attention be paid to two potential issues, both harmful for patients:

1- non-conformities in drug containers
2- non-conformities in the drugs themselves

This compels pharmaceutical companies to look for new technologies capable of responding to these requirements.

SHORTCOMINGS OF CURRENT INSPECTION METHODS

In the pharma industry the quality control procedures can be divided into two types of technology: visual inspection techniques on one hand, and X-ray inspection techniques on the other. They both have pros and cons, and they are currently complementary and both necessary.

PROS

CONS

VISUAL INSPECTION TECHNIQUES * when using human visual inspection
* when using electronic camera inspection

PRO

Effective in detecting non-transparent foreign bodies, if containers and drugs are transparent. Possibility to discover new foreign bodies or container defects thanks to human expertise .
Controls on the entire production line.

CONS

Ineffective in case of non-transparent drugs or containers.
Analysis of small samples.
Quality control dependent on potential human errors.
Impossibility to detect and classify new defect types.

CONVENTIONAL X-RAY SYSTEMS (X-RAY FLUORESCENCE - XRF AND X-RAY DIFFRACTION - XRD)

PRO

Valuable information about the chemical properties of the samples tested.

CONS

Complexity of the instruments involved.
Very slow inspection process, therefore rather suitable for laboratory environments.
Need for highly skilled technical staff.

One more step for a better health

The XSpectra® technology can take quality and safety in the pharma production to the next level.

WHY Xspectra® IS A MUST-HAVE SOLUTION?

Given the current situation, our innovative inspection XSpectra® makes it possible to go the extra mile, combining different technologies and their benefits. It thus provides for a complete and fast inspection, and identifies defects and contaminants non-detectable by the current technologies.

XSPECTRA

CURRENT CHALLENGES

ACHIEVEMENTS

RESULTS

CURRENT CHALLENGES

Contamination of pharmaceutical products

XSPECTRA

ACHIEVEMENTS

Contamination of pharmaceutical products

RESULTS

Quality and safety of products

Keep the patients safe and the pharma industry performant!

CURRENT CHALLENGES

Non-detectable contaminants

XSPECTRA

ACHIEVEMENTS

Non-detectable contaminants

RESULTS

Quality and safety of products

Keep the patients safe and the pharma industry performant!

CURRENT CHALLENGES

Slow inspection process

XSPECTRA

ACHIEVEMENTS

Slow inspection process

RESULTS

Response to an ever-growing production .
Management operations quick, simplified and efficient.

Keep the patients safe and the pharma industry performant!

CURRENT CHALLENGES

Inspection of small samples

XSPECTRA

ACHIEVEMENTS

Inspection of small samples

RESULTS

Response to an ever-growing production .
Management operations quick, simplified and efficient.

Keep the patients safe and the pharma industry performant!

CURRENT CHALLENGES

Need for high-skilled technicians

XSPECTRA

ACHIEVEMENTS

Need for high-skilled technicians

RESULTS

Response to an ever-growing production.
Management operations quick, simplified and efficient.

Keep the patients safe and the pharma industry performant!

SAFE MEDICINES FOR HEALTHIER LIVING

The XSpectra® technology can take quality and safety in the pharma production to the next level.

Technology

Do you want to know more
about our technology?

Contacts Request your test catalogue
XSpectra - detection

This website uses cookies to improve your experience. Using this website you consent to the use of cookies. Learn more